This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Explore which regional ETF yields the highest and the factors behind regional performance. Understand implications for income-focused portfolios.
22,246 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Intel kicked off a high-volume enterprise processor launch, lifting the stock as investors weigh the company’s path b...
Institutional moves can reshape a niche tech stock overnight. This article breaks down the recent liquidation by Loun...
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Markets are sizzling, but does that change the wisdom of simply following the S&P 500? This guide breaks down the rea...
Treasury's crypto policy lead is pushing for CLARITY Act passage by summer 2026 and signaling a cautious, deliberatel...
Micron stock has faced a pullback as market focus shifts from AI optimism to risk management. This article breaks dow...
As portfolios tilt toward a handful of tech giants, AVUV provides a diversified counterweight. This story explains ho...
A drone sector rally sparked a sharp move in a related stock, grabbing headlines and attention. This guide breaks dow...
A ChatGPT-powered forecast associated with Sam Altman lays out a bullish Bitcoin scenario for late 2026, highlighting...
XRp has logged a year of regulatory and liquidity wins, but the price keeps drifting lower. Analysts say macro headwi...
Vistra surged dramatically, but does the rally leave room for gains or is the stock now a trap for late buyers? This ...